MedTrace Logo

Effect of Topical Trimebutine on Pain After Hemorrhoidectomy

NCT03036111 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2017-08-29

No results posted yet for this study

Summary

Trimebutine acts through smooth muscle relaxation. It is presumed that the topical application of trimebutine after hemorrhoidectomy may help relieve pain after the procedure by relaxing the internal anal sphincter spasm.

Conditions

Interventions

DRUG

Trimebutine

Trimebutine suppository will be inserted in the anal canal on completion of hemorrhoidectomy then at six and 12 hours postoperatively.

PROCEDURE

Hemorrhoidectomy

Patients will undergo classic Milliagn-Morgan hemorrhoidectomy

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Sameh H Emile, M.D. · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2018-02-01
Completion
2018-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03036111 on ClinicalTrials.gov